Boosting oncolytic adenovirus potency with magnetic nanoparticles and magnetic force

Molecular Pharmaceutics

Volumn 7, Issue 4, 2010, Pages 1069-1089

  Tresilwised, Nittaya ^a,b   Pithayanukul, Pimolpan ^b   Mykhaylyk, Olga ^a   Holm, Per Sonne ^a   Holzmüller, Regina ^a   Anton, Martina ^a   Thalhammer, Stefan ^c   Adigüzel, Denis ^c   Döblinger, Markus ^d   Plank, Christian ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MAHIDOL UNIVERSITY   (Thailand)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

magnetic drug targeting; magnetic nanoparticles; magnetofection; Oncolytic adenovirus

Indexed keywords

3 [2 (PERFLUOROALKYL)ETHYLTHIO]PROPIONATE; DAUNORUBICIN; IRON OXIDE; LITHIUM DERIVATIVE; MAGNETIC NANOPARTICLE; ONCOLYTIC ADENOVIRUS; PERFLUORO COMPOUND; POLYETHYLENEIMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; CANCER CELL; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; DRUG BINDING; DRUG MECHANISM; DRUG POTENCY; DRUG STABILITY; ELECTRON MICROSCOPY; FEMALE; FETAL CALF SERUM; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; ULTRASTRUCTURE ANALYSIS AND ELECTRON MICROSCOPY; VIRUS ENTRY;

ADENOVIRIDAE; ANIMALS; BLOTTING, SOUTHERN; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MAGNETICS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; ONCOLYTIC VIRUSES; PANCREATIC NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77955241796     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp100123t     Document Type: Article

References (76)

1. Liu, T. C.; Galanis, E.; Kirn, D. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress Nat. Clin. Pract. Oncol. 2007, 4 (2) 101-17
2. Campbell, S. A.; Gromeier, M. Oncolytic viruses for cancer therapy II. Cell-internal factors for conditional growth in neoplastic cells Onkologie 2005, 28 (4) 209-15
3. Campbell, S. A.; Gromeier, M. Oncolytic viruses for cancer therapy I. Cell-external factors: virus entry and receptor interaction Onkologie 2005, 28 (3) 144-9
4. Strauss, R.; Lieber, A. Anatomical and physical barriers to tumor targeting with oncolytic adenoviruses in vivo Curr. Opin. Mol. Ther. 2009, 11 (5) 513-22
5. Walters, R. W.; Grunst, T.; Bergelson, J. M.; Finberg, R. W.; Welsh, M. J.; Zabner, J. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia J. Biol. Chem. 1999, 274 (15) 10219-26
6. Yamamoto, M.; Curiel, D. T. Current issues and future directions of oncolytic adenoviruses Mol. Ther. 2010, 18 (2) 243-50
7. Arnberg, N. Adenovirus receptors: implications for tropism, treatment and targeting Rev. Med. Virol. 2009, 19 (3) 165-78
8. Smith, T. A.; Idamakanti, N.; Marshall-Neff, J.; Rollence, M. L.; Wright, P.; Kaloss, M.; King, L.; Mech, C.; Dinges, L.; Iverson, W. O.; Sherer, A. D.; Markovits, J. E.; Lyons, R. M.; Kaleko, M.; Stevenson, S. C. Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates Hum. Gene Ther. 2003, 14 (17) 1595-604
9. Liu, T. C.; Kirn, D. Gene therapy progress and prospects cancer: oncolytic viruses Gene Ther. 2008, 15 (12) 877-84
10. Cattaneo, R.; Miest, T.; Shashkova, E. V.; Barry, M. A. Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded Nat. Rev. Microbiol. 2008, 6 (7) 529-40
11. Morrison, J.; Briggs, S. S.; Green, N. K.; Thoma, C.; Fisher, K. D.; Kehoe, S.; Seymour, L. W. Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer Hum. Gene Ther. 2009, 20 (3) 239-51
12. Hakkarainen, T.; Sarkioja, M.; Lehenkari, P.; Miettinen, S.; Ylikomi, T.; Suuronen, R.; Desmond, R. A.; Kanerva, A.; Hemminki, A. Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors Hum. Gene Ther. 2007, 18 (7) 627-41
13. Iankov, I. D.; Blechacz, B.; Liu, C.; Schmeckpeper, J. D.; Tarara, J. E.; Federspiel, M. J.; Caplice, N.; Russell, S. J. Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy Mol. Ther. 2007, 15 (1) 114-22
14. Power, A. T.; Bell, J. C. Cell-based delivery of oncolytic viruses: a new strategic alliance for a biological strike against cancer Mol. Ther. 2007, 15 (4) 660-5
15. Huang, J. H.; Zhang, S. N.; Choi, K. J.; Choi, I. K.; Kim, J. H.; Lee, M.; Kim, H.; Yun, C. O. Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-'1BBL Mol. Ther. 2010, 18 (2) 264-74
16. Yoo, J. Y.; Kim, J. H.; Kwon, Y. G.; Kim, E. C.; Kim, N. K.; Choi, H. J.; Yun, C. O. VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth Mol. Ther. 2007, 15 (2) 295-302
17. Bhattarai, S. R.; Kim, S. Y.; Jang, K. Y.; Lee, K. C.; Yi, H. K.; Lee, D. Y.; Kim, H. Y.; Hwang, P. H. N-hexanoyl chitosan-stabilized magnetic nanoparticles: enhancement of adenoviral-mediated gene expression both in vitro and in vivo Nanomedicine 2008, 4 (2) 146-54
18. Bhattarai, S. R.; Kim, S. Y.; Jang, K. Y.; Lee, K. C.; Yi, H. K.; Lee, D. Y.; Kim, H. Y.; Hwang, P. H. Laboratory formulated magnetic nanoparticles for enhancement of viral gene expression in suspension cell line J. Virol. Methods 2008, 147 (2) 213-8
19. Chan, L.; Nesbeth, D.; Mackey, T.; Galea-Lauri, J.; Gaken, J.; Martin, F.; Collins, M.; Mufti, G.; Farzaneh, F.; Darling, D. Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells J. Virol. 2005, 79 (20) 13190-4
20. Chorny, M.; Fishbein, I.; Alferiev, I.; Levy, R. J. Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells Mol. Pharmaceutics 2009, 6 (5) 1380-7
21. Hofmann, A.; Wenzel, D.; Becher, U. M.; Freitag, D. F.; Klein, A. M.; Eberbeck, D.; Schulte, M.; Zimmermann, K.; Bergemann, C.; Gleich, B.; Roell, W.; Weyh, T.; Trahms, L.; Nickenig, G.; Fleischmann, B. K.; Pfeifer, A. Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (1) 44-9
22. Hughes, C.; Galea-Lauri, J.; Farzaneh, F.; Darling, D. Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors Mol. Ther. 2001, 3 (4) 623-30
23. Mah, C.; Fraites, T. J., Jr.; Zolotukhin, I.; Song, S.; Flotte, T. R.; Dobson, J.; Batich, C.; Byrne, B. J. Improved method of recombinant AAV2 delivery for systemic targeted gene therapy Mol. Ther. 2002, 6 (1) 106-12
24. Morizono, K.; Xie, Y.; Helguera, G.; Daniels, T. R.; Lane, T. F.; Penichet, M. L.; Chen, I. S. A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide J. Gene Med. 2009, 11 (8) 655-63
25. Nesbeth, D.; Williams, S. L.; Chan, L.; Brain, T.; Slater, N. K.; Farzaneh, F.; Darling, D. Metabolic biotinylation of lentiviral pseudotypes for scalable paramagnetic microparticle-dependent manipulation Mol. Ther. 2006, 13 (4) 814-22
26. Pandori, M.; Hobson, D.; Sano, T. Adenovirus-microbead conjugates possess enhanced infectivity: a new strategy for localized gene delivery Virology 2002, 299 (2) 204-12
27. Raty, J. K.; Airenne, K. J.; Marttila, A. T.; Marjomaki, V.; Hytonen, V. P.; Lehtolainen, P.; Laitinen, O. H.; Mahonen, A. J.; Kulomaa, M. S.; Yla-Herttuala, S. Enhanced gene delivery by avidin-displaying baculovirus Mol. Ther. 2004, 9 (2) 282-91
28. Scherer, F.; Anton, M.; Schillinger, U.; Henke, J.; Bergemann, C.; Kruger, A.; Gansbacher, B.; Plank, C. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo Gene Ther. 2002, 9 (2) 102-9
29. Tai, M. F.; Chi, K. M.; Lau, K. H. W.; Baylink, D. J.; Chen, S. T. Generation of magnetic retroviral vectors with magnetic nanoparticles Rev. Adv. Mater. Sci. 2003, 5, 319-23
30. Wang, X.; Mani, P.; Sarkar, D. P.; Roy-Chowdhury, N.; Roy-Chowdhury, J. Ex vivo gene transfer into hepatocytes Methods Mol. Biol. 2009, 481, 117-40
31. Plank, C.; Anton, M.; Rudolph, C.; Rosenecker, J.; Krotz, F. Enhancing and targeting nucleic acid delivery by magnetic force Expert Opin. Biol. Ther. 2003, 3 (5) 745-58
32. Kamei, K.; Mukai, Y.; Kojima, H.; Yoshikawa, T.; Yoshikawa, M.; Kiyohara, G.; Yamamoto, T. A.; Yoshioka, Y.; Okada, N.; Seino, S.; Nakagawa, S. Direct cell entry of gold/iron-oxide magnetic nanoparticles in adenovirus mediated gene delivery Biomaterials 2009, 30 (9) 1809-14
33. Haley, K. P.; Overhauser, J.; Babiss, L. E.; Ginsberg, H. S.; Jones, N. C. Transformation properties of type 5 adenovirus mutants that differentially express the E1A gene products Proc. Natl. Acad. Sci. U.S.A. 1984, 81 (18) 5734-8
34. Wong, H. K.; Ziff, E. B. Complementary functions of E1a conserved region 1 cooperate with conserved region 3 to activate adenovirus serotype 5 early promoters J. Virol. 1994, 68 (8) 4910-20
35. Holm, P. S.; Bergmann, S.; Jurchott, K.; Lage, H.; Brand, K.; Ladhoff, A.; Mantwill, K.; Curiel, D. T.; Dobbelstein, M.; Dietel, M.; Gansbacher, B.; Royer, H. D. YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoter J. Biol. Chem. 2002, 277 (12) 10427-34
36. Holm, P. S.; Lage, H.; Bergmann, S.; Jurchott, K.; Glockzin, G.; Bernshausen, A.; Mantwill, K.; Ladhoff, A.; Wichert, A.; Mymryk, J. S.; Ritter, T.; Dietel, M.; Gansbacher, B.; Royer, H. D. Multidrug-resistant cancer cells facilitate E1-independent adenoviral replication: impact for cancer gene therapy Cancer Res. 2004, 64 (1) 322-8
37. Holm, P. S.; Scanlon, K. J.; Dietel, M. Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-'181RDB) by introduction of a hammerhead ribozyme Br. J. Cancer 1994, 70 (2) 239-43
38. Mykhaylyk, O.; Antequera, Y. S.; Vlaskou, D.; Plank, C. Generation of magnetic nonviral gene transfer agents and magnetofection in vitro Nat. Protoc. 2007, 2 (10) 2391-411
39. Mykhaylyk, O.; Vlaskou, D.; Tresilwised, N.; Pithayanukul, P.; Moller, W.; Plank, C. Magnetic nanoparticle formulations for DNA and siRNA delivery J. Magn. Magn. Mater. 2007, 311, 275-81
40. Kowalski, J. B.; Tallentire, A. Substantiation of 25 kGy as a sterilization dose: a rational approach to establishing verification dose Radiat. Phys. Chem. 1999, 54 (1) 55-64
41. Kril, C. E.; Birringer, R. Estimating grain-size distributions in nanocrystalline materials from X-ray diffraction profile analysis Philos. Mag. A 1998, 77 (3) 621-40
42. Mittereder, N.; March, K. L.; Trapnell, B. C. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy J. Virol. 1996, 70 (11) 7498-509
43. Mykhaylyk, O.; Zelphati, O.; Hammerschmid, E.; Anton, M.; Rosenecker, J.; Plank, C. Recent advances in magnetofection and its potential to deliver siRNAs in vitro Methods Mol. Biol. 2009, 487, 111-46
44. Mykhaylyk, O.; Zelphati, O.; Rosenecker, J.; Plank, C. siRNA delivery by magnetofection Curr. Opin. Mol. Ther. 2008, 10 (5) 493-505
45. Hanson, C. V.; Riggs, J. L.; Lennette, E. H. Photochemical inactivation of DNA and RNA viruses by psoralen derivatives J. Gen. Virol. 1978, 40 (2) 345-58
46. Horcas, I.; Fernandez, R.; Gomez-Rodriguez, J. M.; Colchero, J.; Gomez-Herrero, J.; Baro, A. M. WSXM: a software for scanning probe microscopy and a tool for nanotechnology Rev. Sci. Instrum. 2007, 78 (1 013705
47. Stilwell, J. L.; McCarty, D. M.; Negishi, A.; Superfine, R.; Samulski, R. J. Development and characterization of novel empty adenovirus capsids and their impact on cellular gene expression J. Virol. 2003, 77 (23) 12881-5
48. Berridge, M. V.; Herst, P. M.; Tan, A. S. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction Biotechnol. Annu. Rev. 2005, 11, 127-52
49. Mueller, H.; Kassack, M. U.; Wiese, M. Comparison of the usefulness of the MTT, ATP, and calcein assays to predict the potency of cytotoxic agents in various human cancer cell lines J. Biomol. Screening 2004, 9 (6) 506-15
50. Barcroft, J.; Hill, A. V. The nature of oxyhaemoglobin, with a note on its molecular weight J. Physiol. 1910, 39 (6) 411-28
51. Levasseur, L. M.; Slocum, H. K.; Rustum, Y. M.; Greco, W. R. Modeling of the time-dependency of in vitro drug cytotoxicity and resistance Cancer Res. 1998, 58 (24) 5749-61
52. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening J. Natl. Cancer Inst. 1990, 82 (13) 1107-12
53. Riess, J. G. Fluorous micro- and nanophases with a biomedical perspective Tetrahedron 2002, 58 (20) 4113-4131
54. Boussif, O.; Lezoualc'h, F.; Zanta, M. A.; Mergny, M. D.; Scherman, D.; Demeneix, B.; Behr, J. P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine Proc. Natl. Acad. Sci. U.S.A. 1995, 92 (16) 7297-301
55. Wilhelm, C.; Gazeau, F.; Bacri, J. C. Magnetophoresis and ferromagnetic resonance of magnetically labeled cells Eur. Biophys. J. 2002, 31 (2) 118-25
56. Choi, H.; Charnsangavej, C.; Faria, S. C.; Macapinlac, H. A.; Burgess, M. A.; Patel, S. R.; Chen, L. L.; Podoloff, D. A.; Benjamin, R. S. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria J. Clin. Oncol. 2007, 25 (13) 1753-9
57. Van den Abbeele, A. D. The lessons of GIST - PET and PET/CT: a new paradigm for imaging Oncologist 2008, 13 (Suppl. 2) 8-13
58. Damm, E. M.; Pelkmans, L.; Kartenbeck, J.; Mezzacasa, A.; Kurzchalia, T.; Helenius, A. Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae J. Cell Biol. 2005, 168 (3) 477-88
59. Medina-Kauwe, L. K. Endocytosis of adenovirus and adenovirus capsid proteins Adv. Drug Delivery Rev. 2003, 55 (11) 1485-96
60. Shimony, N.; Elkin, G.; Kolodkin-Gal, D.; Krasny, L.; Urieli-Shoval, S.; Haviv, Y. S. Analysis of adenoviral attachment to human platelets Virol. J. 2009, 6, 25
61. Villanueva, A.; Canete, M.; Roca, A. G.; Calero, M.; Veintemillas- Verdaguer, S.; Serna, C. J.; Morales Mdel, P.; Miranda, R. The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells Nanotechnology 2009, 20 (11) 115103
62. Sonawane, N. D.; Szoka, F. C., Jr.; Verkman, A. S. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes J. Biol. Chem. 2003, 278 (45) 44826-31
63. Kim, J. H.; Lee, Y. S.; Kim, H.; Huang, J. H.; Yoon, A. R.; Yun, C. O. Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy J. Natl. Cancer Inst. 2006, 98 (20) 1482-93
64. Ganesh, S.; Gonzalez Edick, M.; Idamakanti, N.; Abramova, M.; Vanroey, M.; Robinson, M.; Yun, C. O.; Jooss, K. Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice Cancer Res. 2007, 67 (9) 4399-407
65. Veiseh, O.; Gunn, J. W.; Zhang, M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging Adv. Drug Delivery Rev. 2010, 62 (3) 284-304
66. Pradhan, P.; Giri, J.; Rieken, F.; Koch, C.; Mykhaylyk, O.; Doblinger, M.; Banerjee, R.; Bahadur, D.; Plank, C. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy J. Controlled Release 2010, 142 (1) 108-21
67. Thiesen, B.; Jordan, A. Clinical applications of magnetic nanoparticles for hyperthermia Int. J. Hyperthermia 2008, 24 (6) 467-74
68. Lubbe, A. S.; Alexiou, C.; Bergemann, C. Clinical applications of magnetic drug targeting J. Surg. Res. 2001, 95 (2) 200-6
69. Medarova, Z.; Pham, W.; Farrar, C.; Petkova, V.; Moore, A. In vivo imaging of siRNA delivery and silencing in tumors Nat. Med. 2007, 13 (3) 372-7
70. Perez, J. M.; Simeone, F. J.; Saeki, Y.; Josephson, L.; Weissleder, R. Viral-induced self-assembly of magnetic nanoparticles allows the detection of viral particles in biological media J. Am. Chem. Soc. 2003, 125 (34) 10192-3
71. Manchester, M.; Singh, P. Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging Adv. Drug Delivery Rev. 2006, 58 (14) 1505-22
72. Saini, V.; Martyshkin, D. V.; Mirov, S. B.; Perez, A.; Perkins, G.; Ellisman, M. H.; Towner, V. D.; Wu, H.; Pereboeva, L.; Borovjagin, A.; Curiel, D. T.; Everts, M. An adenoviral platform for selective self-assembly and targeted delivery of nanoparticles Small 2008, 4 (2) 262-9
73. Singh, R.; Kostarelos, K. Designer adenoviruses for nanomedicine and nanodiagnostics Trends Biotechnol. 2009, 27 (4) 220-9
74. Loebinger, M. R.; Kyrtatos, P. G.; Turmaine, M.; Price, A. N.; Pankhurst, Q.; Lythgoe, M. F.; Janes, S. M. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles Cancer Res. 2009, 69 (23) 8862-7
75. Riegler, J.; Wells, J. A.; Kyrtatos, P. G.; Price, A. N.; Pankhurst, Q. A.; Lythgoe, M. F. Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system Biomaterials 2010, 31 (20) 5366-71
76. Kreppel, F.; Kochanek, S. Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide Mol. Ther. 2008, 16 (1) 16-29